Key Metrics
8.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Oncology
SJR
- Q2 Oncology
- Q1 Hematology
- Q2 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.39
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
27%
4 to 6 months
47%
7 to 9 months
19%
Above 9 months
8%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Hepatocellular carcinoma
- Notch signaling pathway
- Bone marrow
- Protein kinase A
- Maximum tolerated dose
- Overall survival
- Photopheresis
- Chimeric antigen receptor
- Peripheral T-cell lymphoma
- Post-transcriptional regulation
- Arsenic
- Diffuse large B-cell lymphoma
- Clinical trial
- Cell therapy
- Fusion gene
- Polycythemia vera
- Immunotherapy
- Phosphoglycerate dehydrogenase
- Burden of disease
- Untranslated region
Journal Specifications
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2590 | USD 2990 | GBP 2290 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 6 |
| Article Processing Charges | EUR 2590 | USD 2990 | GBP 2290 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
Planning to publish in Experimental Hematology and Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
- 4 Dec 24
- Experimental Hematology & Oncology
-
Full paper
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
- 28 Nov 24
- Experimental Hematology & Oncology
-
Full paper
CUL4A-DDB1-circRFWD2 E3 ligase complex mediates the ubiquitination of p27 to promote multiple myeloma proliferation
- 22 Nov 24
- Experimental Hematology & Oncology
-
Full paper
Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources
- 15 Nov 24
- Experimental Hematology & Oncology
-
Full paper
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities
- 13 Nov 24
- Experimental Hematology & Oncology
-
Full paper
High-throughput screening for optimizing adoptive T cell therapies
- 13 Nov 24
- Experimental Hematology & Oncology
Scite analysis
Powered by scite_
672 articles received 10.1k citations see all
- 292 Supporting
- 9,552 Mentioning
- 39 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 6 Corrections
- 6 Errata
- 0 Expression of Concern
FAQs
How long has Experimental Hematology and Oncology been actively publishing?
Experimental Hematology and Oncology has been in operation since 2012 till date.
What is the publishing frequency of Experimental Hematology and Oncology ?
Experimental Hematology and Oncology published with a Continuous publication frequency.
How many articles did Experimental Hematology and Oncology publish last years ?
In 2023, Experimental Hematology and Oncology published 105 articles.
What is the eISSN & pISSN for Experimental Hematology and Oncology ?
For Experimental Hematology and Oncology,eISSN is 2162-3619 and pISSN is2162-3619.
What is Citescore for Experimental Hematology and Oncology ?
Citescore for Experimental Hematology and Oncology is 8.1.
What is SNIP score for Experimental Hematology and Oncology ?
SNIP score for Experimental Hematology and Oncology is 1.39.
What is the SJR for Experimental Hematology and Oncology ?
SJR for Experimental Hematology and Oncology is Q2.
Who is the publisher of Experimental Hematology and Oncology ?
BMC is the publisher of Experimental Hematology and Oncology.